Nombre de documents

31

CV de Sabine Mazerbourg


Communication dans un congrès17 documents

  • Isabelle Grillier-Vuissoz, Sandra Kuntz, Sabine Mazerbourg, Christelle Colin-Cassin, Marine Geoffroy, et al.. Le repositionnement de la TGZ, une stratégie intéressante pour le traitement des tumeurs mammaires triple-négatives?. 3ème Journée d’échanges sur la recherche en cancérologie en Lorraine, Oct 2016, Vandoeuvre-lès-Nancy, France. 2016. <hal-01418787>
  • Michel Boisbrun, Andrea Bordessa, Audrey Berthe, Marine Geoffroy, Hélène Martin, et al.. Le « drug reprofiling » appliqué à la troglitazone : vers un nouveau traitement anticancéreux ? . 16èmes REncontres de Chimie Organique Biologique, Recob.16, Mar 2016, Aussois, France. <http://www.recob-tlse.org/>. <hal-01416900>
  • Audrey Berthe, Stéphanie Grandemange, Michel Boisbrun, Bost Frédéric, Marie Zaffino, et al.. Delta-2-Troglitazone targets mitochondria in triple-negative breast cancer cells: a metabolic change contributing to sensitization of cancer cells to chemotherapy? . 9e Forum du Cancéropôle Grand Est , Nov 2015, Strasbourg, France. <hal-01243561>
  • Claire Barbieux, Grégory Francius, Rémi Klotz, Marie Ennen, Vanessa Besancenot, et al.. The transcriptional regulator DDB2 modulates TGF beta 1 signaling and cell adhesion in breast cancer cells. 8ème forum du Cancéropôle Grand-Est, Nov 2014, Strasbourg, France. <hal-01100733>
  • Christelle Colin-Cassin, Xiao Yao, Claudia Cerella, Audrey Berthe, Sarra Chbicheb, et al.. The potential energy restriction mimetic agent delta2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells. Metabolism 2014: Alterations of metabolic pathways as therapeutic targets, Jan 2014, Esch-sur-Alzette, Luxembourg. <hal-01095563>
  • Andrea Bordessa, Christelle Colin-Cassin, Isabelle Grillier-Vuissoz, Sandra Kuntz, Sabine Mazerbourg, et al.. Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds. International Symposium "Molecular Sciences: Facing Up to Major Societal Challenges", Oct 2014, Nancy, France. <hal-01094602>
  • Audrey Berthe, Michel Boisbrun, Stéphane Flament, Sabine Mazerbourg. ∆2-Troglitazone and 2-Deoxyglucose inhibit breast cancer cell proliferation: a consequence of the alteration of the cancer cell metabolism?. 8ème forum du Cancéropôle Grand-Est, Nov 2014, Strasbourg, France. 2014. <hal-01094607>
  • Christelle Colin-Cassin, Xiao Yao, Claudia Cerella, Audrey Berthe, Sarra Chbicheb, et al.. The potential energy restriction mimetic agent Delta2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells. Metabolism 2014.
 Alterations of metabolic pathways as therapeutic targets, Jan 2014, Esch-sur Alzette, Luxembourg. <hal-01094413>
  • Andrea Bordessa, Christelle Colin-Cassin, Isabelle Grillier-Vuissoz, Sandra Kuntz, Sabine Mazerbourg, et al.. Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds. 50th International Conference on Medicinal Chemistry, RICT 2014, Jul 2014, Rouen, France. <hal-01094539>
  • Isabelle Grillier-Vuissoz, Christelle Colin-Cassin, Xiao Yao, Claudia Cerella, Audrey Berthe, et al.. Effects of the potential energy restriction mimetic agent delta2-troglitazone in breast cancer cells. 23rd Biennial Congress of the European Association for Cancer Research, EACR-23, Jul 2014, Munich, Germany. 50 (S5), pp.S57-S58, 2014. <hal-01094634>
  • Michel Boisbrun, Andrea Bordessa, Stéphane Salamone, M. Vo, Christelle Colin, et al.. Effets PPARgamma indépendants des glitazones : vers le développement de dérivés de troglitazone à visée anticancéreuse. 14èmes Rencontres en Chimie Organique Biologique, RECOB 14, Mar 2012, Aussois, France. pp.CDROM, 2012. <hal-00747910>
  • Michel Boisbrun, Andrea Bordessa, Stéphane Salamone, M. Vo, Christelle Colin, et al.. Synthèse de nouveaux dérivés de troglitazone à visée anticancéreuse. Congrès SCF Grand-Est 7, Mar 2012, Reims, France. pp.CDROM, 2012. <hal-00747913>
  • Christelle Colin, Sarra Chbicheb, Xiao Yao, Andrea Bordessa, Michel Boisbrun, et al.. New thiazolidinedione derivatives with PPARg-independent activity: high inhibition of breast cancer cell proliferation with low toxicity towards human hepatocytes. 22nd Biennial Congress of the European Association for Cancer Research, EACR-22, Jul 2012, Barcelone, Spain. pp.CDROM, 2012, <10.1016/S0959-8049(12)71613-1>. <hal-00747357>
  • Christelle Colin, Stéphane Flament, Michel Boisbrun, Hélène Martin, Yves Chapleur, et al.. Elaboration de nouveaux dérivés de thiazolidinediones à activité PPARgamma-indépendante pour le traitement des cancers mammaires. 7ème Journée Claude HURIET de Recherche Biomédicale du CHU & Faculté de Médecine de Nancy, Mar 2012, Vandoeuvre-les-Nancy, France. <hal-00747515>
  • Ali Karoune, Xiao Yao, Michel Boisbrun, Yves Chapleur, Sandra Kuntz, et al.. Etude du facteur de transcription précoce Nur77/NR4A1 dans les cellules cancéreuses mammaires : intérêt pour la compréhension du mode d'action des thiazolidinediones. 6ème Forum du Cancéropole Grand-Est, Nov 2012, Strasbourg, France. <hal-00747532>
  • Christelle Colin, Sarra Chbicheb, Michel Boisbrun, Isabelle Grillier-Vuissoz, Sandra Kuntz, et al.. PPARgamma-independent effects of thiazolidinediones: a promising mechanism for new anticancer drugs. 5ème Forum du Cancéropôle Grand-Est, Nov 2011, Strasbourg, France. <hal-00747832>
  • Christelle Colin, Sarra Chbicheb, Michel Boisbrun, Isabelle Grillier-Vuissoz, Sandra Kuntz, et al.. PPARgamma-independent activity of thiazolidinediones: a promising mechanism of action for new anticancer drugs. 2ème Colloque Inter-régional Grand-Est de Recherche Translationnelle en Oncologie, ONCOTRANS 2011, Sep 2011, Nancy, France. <hal-00747856>

Article dans une revue11 documents

  • Audrey Berthe, Stéphane Flament, Stéphanie Grandemange, Marie Zaffino, Michel Boisbrun, et al.. Δ2-Troglitazone promotes cytostatic rather than pro-apoptotic effects in breast cancer cells cultured in high serum conditions. Cell Cycle, Taylor & Francis, 2016, 15 (24), pp.3402-3412. <10.1080/15384101.2016.1245248>. <hal-01411104>
  • Sabine Mazerbourg, Sandra Kuntz, Isabelle Grillier-Vuissoz, Audrey Berthe, Marine Geoffroy, et al.. Reprofiling of troglitazone towards more active and less toxic derivatives: a new hope for cancer treatment?. Current Topics in Medicinal Chemistry, Bentham Science Publishers, 2016, 16 (19), pp.2115-2124. <10.2174/1568026616666160216153036>. <hal-01281602>
  • Christelle Colin-Cassin, Xiao Yao, Claudia Cerella, Sarra Chbicheb, Sandra Kuntz, et al.. PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.. Molecular Carcinogenesis, Wiley, 2015, 54 (5), pp.393-404. <10.1002/mc.22109>. <hal-00917939>
  • Andrea Bordessa, Christelle Colin-Cassin, Isabelle Grillier-Vuissoz, Sandra Kuntz, Sabine Mazerbourg, et al.. Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds.. European Journal of Medicinal Chemistry, Elsevier, 2014, 83, pp.129-140. <10.1016/j.ejmech.2014.06.015>. <hal-01094210>
  • Sandra Kuntz, Sabine Mazerbourg, Michel Boisbrun, Claudia Cerella, Marc Diederich, et al.. Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones.. Biochemical Pharmacology, Elsevier, 2014, 92 (1), pp.102-111. <10.1016/j.bcp.2014.07.021>. <hal-01094216>
  • Isabelle Grillier-Vuissoz, Sabine Mazerbourg, Michel Boisbrun, Sandra Kuntz, Yves Chapleur, et al.. PPARγ-independent activity of thiazolidinediones: a promising mechanism of action for new anticancer drugs?. Journal of Carcinogenesis & Mutagenesis, 2012, pp.S8:002. <10.4172/2157-2518.S8-002>. <hal-00747318>
  • Stéphane Salamone, Christelle Colin, Isabelle Grillier-Vuissoz, Sandra Kuntz, Sabine Mazerbourg, et al.. Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study. European Journal of Medicinal Chemistry, Elsevier, 2012, 51, pp.206-215. <10.1016/j.ejmech.2012.02.044>. <hal-00746870>
  • Sarra Chbicheb, Xiao Yao, Jean-Luc Rodeau, Stéphane Salamone, Michel Boisbrun, et al.. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.. Biochemical Pharmacology, Elsevier, 2011, 81 (9), pp.1087-1097. <10.1016/j.bcp.2011.02.006>. <hal-00747770>
  • Sarra Chbicheb, Xiao Yao, Jean-Luc Rodeau, Stéphane Salamone, Michel Boisbrun, et al.. EGR1 expression: a calcium and ERK1/2 mediated PPAR-independent event involved in the antiproliferative effect of 15-deoxy-(12,14-prostaglandin J2 and Thiazolidinediones in breast cancer cells. Biochemical Pharmacology, Elsevier, 2011, 81 (9), pp.1087. <10.1016/j.bcp.2011.02.006>. <hal-00685074>
  • Laurent David, Christine Mallet, Sabine Mazerbourg, Jean-Jacques Feige, Sabine Bailly. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.. Blood, American Society of Hematology, 2007, 109 (5), pp.1953-61. <10.1182/blood-2006-07-034124>. <inserm-00376097>
  • Sabine Mazerbourg, Isabelle Callebaut, Jürgen Zapf, Subburaman Mohan, Michael Overgaard, et al.. Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society., 2004, 14, pp.71-84. <10.1016/j.ghir.2003.10.002>. <hal-00086349>

Poster3 documents

  • Audrey Berthe, Stéphanie Grandemange, Michel Boisbrun, Bost Frédéric, Marie Zaffino, et al.. Delta-2-troglitazone sensitizez triple-negative breast cancer cells to chemotherapy: a consequence of mitochondrial dysfunction?. 6th World Congress on Targeting Mitochondria, Oct 2015, Berlin, Germany. 2015. <hal-01214922>
  • Audrey Berthe, Stéphanie Grandemange, Michel Boisbrun, Bost Frédéric, Stéphane Flament, et al.. D2-Troglitazone alters energetic metabolism in triple-negative breast cancer cells: a mechanism to sensitize cancer cells to chemotherapy? . Cancer and Metabolism conference, 2015, Sep 2015, Cambridge, United Kingdom. <http://www.abcam.com/events/cancer-and-metabolism-conference-2015>. <hal-01214915>
  • Audrey Berthe, Andrea Bordessa, Michel Boisbrun, Stéphane Flament, Sabine Mazerbourg. Anchorage of ∆2-Troglitazone on the dendrimer PAMAM demonstrates that early events in breast cancer cells occur independently of a nuclear action. 7ème forum Cancéropôle Grand-Est, Nov 2013, Strasbourg, France. page 40 résumé 31. <hal-00919936>